| http://www.w3.org/ns/prov#value | - For the purposes of the nongyn program, and contrary to how we are to practice in a clinical setting, any ARC challenge interpreted as a low-grade squamous intraepithelial lesion (LSIL), high-grade squamous intraepithelial lesion (HSIL), squamous cell carcinoma, or other malignant neoplasm should be categorized by participants as ???positive for malignancy??? on the results form.
|
